Transatlantique Private Wealth’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Transatlantique Private Wealth's BMY Position: Q3 2025 in Review
Transatlantique Private Wealth sold out of Bristol-Myers Squibb (BMY) in Q3 2025, closing a stake of 4,555 shares — an estimated $211K sold.
Transatlantique Private Wealth first reported a position in BMY in Q2 2022 and held it in 13 quarters. The position peaked at $1.33M in Q1 2024. 2,268 funds tracked by Wall St. Rank hold BMY as of Q3 2025.
- Transatlantique Private Wealth reported no remaining Bristol-Myers Squibb position as of Q3 2025 after selling out during the quarter.
- Transatlantique Private Wealth sold 4,555 Bristol-Myers Squibb shares in Q3 2025, an estimated $211K.
- Transatlantique Private Wealth first reported a position in Bristol-Myers Squibb in Q2 2022 and held it in 13 quarters.
- Transatlantique Private Wealth's Bristol-Myers Squibb position peaked at $1.33M in Q1 2024.
- 2,268 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2025.
Based on Transatlantique Private Wealth's 13F filing for Q3 2025, filed 10 Nov 2025.